Precision Medicine Research Center, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
Integrated Research Center for Genome Polymorphism, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
Exp Mol Med. 2022 Mar;54(3):263-272. doi: 10.1038/s12276-022-00740-0. Epub 2022 Mar 11.
Despite growing evidence of the relevance of alternative splicing (AS) to cancer development and progression, the biological implications of AS for tumor behaviors, including papillary thyroid cancer (PTC), remain elusive. With the aim of further understanding the molecular and histological subtypes of PTC, we in this study explored whether AS events might act as new molecular determinants. For this purpose, AS profiles were analyzed in RNA-sequencing data from The Cancer Genome Atlas (TCGA) and from a Korean patient dataset. A total of 23 distinct exon-skipping (ES) events that correlated significantly with PTC oncogenic activity and differentiation scores were identified. The two top-ranked ES events, NUMA1_17515 in exon 18 of NUMA1 and TUBB3_38175 in exon 6 of TUBB3, showed high correlations with oncogenic activities and discriminated histological and molecular subtypes of PTC. Furthermore, two novel intron-retention (IR) events for TUBB3 were uncovered. All ES and IR events for the TUBB3 gene were predicted to induce nonsense-mediated mRNA decay. The relative abundances of intron reads in the PTC dataset from TCGA showed IR levels to differ significantly among PTC subtypes, possibly reflecting their different tumor behaviors. This study provides a landscape of AS changes among PTC subtypes and identified two significant AS events, NUMA1_17515 and TUBB3_38175, as potential AS biomarkers for PTC subclassification and characterization. The AS events identified in this study may be involved in the development of phenotypic differences underlying the functional characteristics and histological differentiation of PTCs.
尽管越来越多的证据表明可变剪接(AS)与癌症的发生和发展有关,但 AS 对肿瘤行为的生物学意义,包括甲状腺乳头状癌(PTC),仍然难以捉摸。本研究旨在进一步了解 PTC 的分子和组织学亚型,探讨 AS 事件是否可以作为新的分子决定因素。为此,我们分析了来自癌症基因组图谱(TCGA)和韩国患者数据集的 RNA-seq 数据中的 AS 谱。鉴定出 23 个与 PTC 致癌活性和分化评分显著相关的独特外显子跳跃(ES)事件。排名前两位的 ES 事件,NUMA1_17515 在 NUMA1 的外显子 18 中,TUBB3_38175 在 TUBB3 的外显子 6 中,与致癌活性高度相关,并区分了 PTC 的组织学和分子亚型。此外,还发现了 TUBB3 的两个新的内含子保留(IR)事件。TUBB3 基因的所有 ES 和 IR 事件均预测会诱导无意义介导的 mRNA 降解。TCGA 的 PTC 数据集中外显子读取的相对丰度显示,IR 水平在 PTC 亚型之间存在显著差异,这可能反映了它们不同的肿瘤行为。本研究提供了 PTC 亚型中 AS 变化的全景图,并确定了两个重要的 AS 事件,NUMA1_17515 和 TUBB3_38175,作为 PTC 亚分类和特征的潜在 AS 生物标志物。本研究中鉴定的 AS 事件可能与 PTC 功能特征和组织学分化的表型差异的发展有关。